Skip to main content
The Ultrasound Journal

Table 1 Clinical and demographic characteristics of the patients included in the study

From: Point-of-care lung ultrasound for diagnosis of Pneumocystis jirovecii pneumonia: notes from the field

 

Total n = 24 (100%)

PJP+ n = 14 (58.33%)

PJP− n = 10 (41.66%)

p-value

Sex males/females (% males)

18/6 (75.00%)

13/1 (92.85%)

5/5 (50.00%)

0.0501

Median age in years (IQR)

44 (36–53)

43 (35–54)

44 (41–51)

0.8602

Ethnic origin (n)

 Caucasian

18

11

7

 

 African

3

1

2

 

 Latin-American

3

2

1

 

Median CD4+ T cells/μl on admission (IQR)

56.5 (18–172.25)

39.5 (16–73.5)

137.5 (59.75–325)

0.0608

Median viral load in copies/ml on admission (IQR)

345,000 (91,427–607,400)

262,450 (61,291–587,150)

391,200 (195,400–790,400)

0.8291

PJP as first AIDS-defining condition

n.a.

13/14 (92.85%)

n.a.

 

Final diagnosis

–

PJP

See notea

 
  1. PJP, Pneumocystis jirovecii pneumonia; IQR, inter quartile range; n.a., not applicable
  2. aFinal diagnoses of PJP-patients: bacterial pneumonia (n = 3), TB (n = 3), disseminated Cytomegalovirus infection (n = 1) and Mycobacterium avium complex infection (n = 1) with lung involvement, non-Hodgkin’s T cell lymphoma (n = 1) and adenocarcinoma (n = 1) of the lung
Back to article page